A Mark Wan

Affiliations

  • Director at Acelrx Pharmaceuticals Inc (ACRX), 2023-12-13
  • Executive Chairman at Athlon Acquisition Corp. (SWETU), 2021-01-12
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-11-20
  • Other at Nevro Corp (NVRO), 2014-11-12
  • Director at Epocrates Inc (EPOC), 2013-03-14
  • Large Shareholder at Liposcience Inc (LPDX), 2013-02-01
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACRX $3.31 52,213 Large Shareholder, Director 139,621 2012-12-07 Filing
ACRX $3.31 2,364,705 Large Shareholder, Director 6,323,534 2012-12-07 Filing
ACRX $3.40 4,613 Large Shareholder, Director 87,408 2012-05-29 Filing
ACRX $3.40 208,911 Large Shareholder, Director 3,958,829 2012-05-29 Filing
ACRX $3.40 3,631 Large Shareholder, Director 199,174 2012-05-29 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACRX $12.36 11,250 Large Shareholder, Director 126,153 2014-03-10 Filing
ACRX $11.96 459 Large Shareholder, Director 137,403 2014-03-07 Filing
ACRX $12.39 1,759 Large Shareholder, Director 137,862 2014-03-07 Filing
ACRX $12.36 509,520 Large Shareholder, Director 5,713,569 2014-03-10 Filing
ACRX $11.96 20,800 Large Shareholder, Director 6,223,089 2014-03-07 Filing